Apotex Inc. v. Merck Canada Inc. and Merck Frosst Canada & Co

Drug: alendronate

The Court had previously provided a judgment, resolving a number of matters in dispute between the parties with respect to the amount of compensation to be paid pursuant to s. 8 of the NOC Regulations (summary here). After consulting with their accountants, one matter remained in dispute. In this decision, the Court adjudicated that matter, which concerned deductions for rebates, and finalized the judgment. The Court also provided guidelines for determining costs and asked the parties to come to an agreement on that sum.